Cardinal Health Research and Development Expenses 2010-2023 | CAH

Cardinal Health annual/quarterly research and development expenses history and growth rate from 2010 to 2023. Research and development expenses can be defined as an expense arising from studies and product development processes.
  • Cardinal Health research and development expenses for the quarter ending December 31, 2023 were $M, a NAN% increase year-over-year.
  • Cardinal Health research and development expenses for the twelve months ending December 31, 2023 were $0M, a NAN% increase year-over-year.
  • Cardinal Health annual research and development expenses for 2023 were $0B, a NAN% decline from 2022.
  • Cardinal Health annual research and development expenses for 2022 were $0B, a NAN% decline from 2021.
  • Cardinal Health annual research and development expenses for 2021 were $0B, a NAN% decline from 2020.
Cardinal Health Annual Research and Development Expenses
(Millions of US $)
2023 $
2022 $
2021 $
2020 $
2019 $
2018 $
2017 $
2016 $
2015 $
2014 $
2013 $
2012 $
2011 $
2010 $
2009 $
Cardinal Health Quarterly Research and Development Expenses
(Millions of US $)
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $24.040B $205.012B
Cardinal Health Inc. is a nation-wide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. The company has two reporting segments: Pharmaceutical and Medical. The Pharmaceutical segment is the second largest pharmaceutical distributor in the United States and the largest nuclear pharmacy. Its products and services include pharmaceutical distribution, manufacturer and specialty services, and nuclear and pharmacy services. The Medical segment manufactures products such as single-use surgical drapes, gowns and apparel; exam and surgical gloves; and fluid suction and collection systems and offers sterile and non-sterile procedure kits. These products are sold directly or distributed via third-party sources in the U.S., Canada, Europe, South America and the Asia/Pacific.?
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $72.241B 20.27
Becton Dickinson (BDX) United States $68.385B 19.35
West Pharmaceutical Services (WST) United States $25.794B 46.23
Align Technology (ALGN) United States $20.594B 39.76
Cooper (COO) United States $19.458B 29.44
Labcorp (LH) United States $17.967B 15.47
Henry Schein (HSIC) United States $9.518B 16.93
DENTSPLY SIRONA (XRAY) United States $5.893B 15.26
Merit Medical Systems (MMSI) United States $4.780B 26.20
CONMED (CNMD) United States $2.325B 21.09
Patterson (PDCO) United States $2.316B 11.09
STAAR Surgical (STAA) United States $2.094B 80.42
Atrion (ATRI) United States $0.802B 42.84
Lifevantage (LFVN) United States $0.092B 11.81
Pro-Dex (PDEX) United States $0.068B 34.40
Biolase (BIOL) United States $0.005B 0.00